A Strategic Roadmap for Synthetic Biology in the UK - 2012

Posted on: 31/07/2012

Synthetic biology has the potential to increase prosperity and address some of the major challenges facing our planet.

A strategic roadmap for synthetic biology was published in July 2012 with the key purpose of developing ‘a roadmap that defines the likely timeframe and actions required to establish a world leading Synthetic Biology industry within the UK.’

The roadmap, produced by an independent panel of experts for the government’s Department for Business Innovation and Skills, sets out a shared vision for realising the potential of synthetic biology in the UK.

Note: A refresh of the 2012 Roadmap, the UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy, was published on 24th February 2016.

Photo galleries are not available for content from the previous KTN website: we apologise for this.

Five core themes for the roadmap emerged from this work. They were:

  • Foundational science and engineering: the need for sufficient capabilities for the UK to maintain a leading edge
  • Continuing responsible research and innovation: including the need for awareness, training and adherence to regulatory frameworks
  • Developing technology for commercial use
  • Applications and markets: identifying growth markets and developing applications
  • International cooperation

To achieve this, the roadmap outlines five key recommendations:

  • Invest in a network of multidisciplinary centres to establish an outstanding UK synthetic biology resource.
  • Build a skilled, energised and well-funded UK-wide synthetic biology community [for example, via the Synthetic Biology Special Interest Group].
  • Invest to accelerate technology responsibly to market.
  • Assume a leading international role.
  • Establish a leadership council

Some of the recommendations made by the Roadmap are already in place, including the Synthetic Biology Special Interest Group (SynBio SIG); funding opportunities, for instance the SPARK Awards for Synthetic Biology and the Technology Strategy Board’s (now known as Innovate UK) £6.5M Feasibility Studies Competition which launched in October 2012; and increased consideration of responsible innovation factors in the funding process. The co-founders are working to ensure that the projects funded perform their activities within the principles of responsible innovation.

Moreover, ~ £20 million of funding has already been made available to support implementation of the Roadmap through a number of initiatives by the BBSRC, EPSRC and Innovate UK.

You can download the Strategic Roadmap for Synthetic Biology in the UK (2012) here.


Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.